Table of Contents
ISRN Analytical Chemistry
Volume 2012, Article ID 281929, 13 pages
http://dx.doi.org/10.5402/2012/281929
Research Article

Fluorometric Determination of Drugs Containing α-Methylene Sulfoxide Functional Groups Using 𝑁 1 - Methylnicotinamide Chloride as a Fluorogenic Agent

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt

Received 10 October 2011; Accepted 13 November 2011

Academic Editors: C. Desiderio and W. Lee

Copyright © 2012 Khaled M. Elokely et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Nakamura and Z. Tamura, “Fluorometric assay of α-methylene carbonyl compounds with N1-methylnicotinamide chloride,” Analytical Chemistry, vol. 50, no. 14, pp. 2047–2051, 1978. View at Google Scholar · View at Scopus
  2. M. A. El Dawy, M. M. Mabrouk, and R. A. El Barbary, “Spectrofluorimetric determination of warfarin sodium by using N1-methylnicotinamide chloride as a fluorigenic agent,” Journal of Association of Official Analytical Chemists International, vol. 88, no. 2, pp. 455–461, 2005. View at Google Scholar
  3. M. A. El Dawy, M. M. Mabrouk, and R. A. El Barbary, “Spectrofluorimetric determination of drugs containing active methylene group using N1-methylnicotinamide chloride as a fluorigenic agent,” Chemical and Pharmaceutical Bulletin, vol. 54, no. 7, pp. 1026–1029, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. K. M. Elokely, M. A. Eldawy, M. A. Elkersh, and T. F. El-Moselhy, “Fluorescence spectrometric determination of drugs containing α-methylene sulfone/sulfonamide functional groups using N1-methylnicotinamide chloride as a fluorogenic agent,” International Journal of Analytical chemistry, vol. 2011, Article ID 840178, 9 pages, 2011. View at Publisher · View at Google Scholar · View at PubMed
  5. R. W. Li, S. W. Seto, A. L. Au et al., “Inhibitory effect of nonsteroidal anti-inflammatory drugs on adenosine transport in vascular smooth muscle cells,” European Journal of Pharmacology, vol. 612, no. 1–3, pp. 15–20, 2009. View at Publisher · View at Google Scholar · View at PubMed
  6. X. Q. Li, T. B. Andersson, M. Ahlström, and L. Weidolf, “Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities,” Drug Metabolism and Disposition, vol. 32, no. 8, pp. 821–827, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. K. Y. Jiang, “Blood gas studies in experimental steam burns of the respiratory tract 1 to 14 days after the injuries,” Zhonghua zheng xing shao shang wai ke za zhi = Zhonghua zheng xing shao shang waikf [i.e. waike] zazhi = Chinese journal of plastic surgery and burns / [Chung-hua cheng hsing shao shang wai k"o tsa chih pien chi wei yuan hui pien ch, vol. 1, no. 3, pp. 190–239, 1985. View at Google Scholar · View at Scopus
  8. D. M. Boland, M. F. Burke, T. Mitchel, and P. Madley, “Development of a generic method to the solid-phase extraction of acidic compounds from complex matrices,” Journal of Analytical Toxicology, vol. 25, no. 7, pp. 602–606, 2001. View at Google Scholar · View at Scopus
  9. L. X. Jiang, “Rapid analysis of sulindac in human serum by HPLC,” Yaowu Fenxi Zazhi, vol. 20, pp. 163–165, 2000. View at Google Scholar
  10. A. Slovakova, X. F. von Maltzan, B. K. Patel, A. F. Drake, and A. J. Hutt, “Chromatographic resolution, chiroptical characterization and urinary excretion of the enantiomers of sulindac,” Chromatographia, vol. 48, no. 5-6, pp. 369–376, 1998. View at Publisher · View at Google Scholar · View at Scopus
  11. B. Unterhalt, S. Baudner, and A. Malcher, “Enzyme immunoassay for the determination of sulindac,” Pharmazie, vol. 53, no. 6, pp. 420–421, 1998. View at Google Scholar · View at Scopus
  12. P. Zhang, G. Xu, J. Xiong et al., “Enhancing the sensitivity of capillary electrophoresis using a microcolumn solid phase extraction setup,” Journal of Separation Science, vol. 26, no. 17, pp. 1527–1532, 2003. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. L. Chen, Y. J. Jong, and S. M. Wu, “Capillary electrophoresis combining field-amplified sample stacking and electroosmotic flow suppressant for analysis of sulindac and its two metabolites in plasma,” Journal of Chromatography A, vol. 1119, no. 1-2, pp. 176–182, 2006. View at Publisher · View at Google Scholar · View at PubMed
  14. F. Salama, N. El-Abasawy, S. A. Abdel Razeq, M. M. F. Ismail, and M. M. Fouad, “Validation of the spectrophotometric determination of omeprazole and pantoprazole sodium via their metal chelates,” Journal of Pharmaceutical and Biomedical Analysis, vol. 33, no. 3, pp. 411–421, 2003. View at Publisher · View at Google Scholar · View at Scopus
  15. K. Karljikovic-Rajic, D. Novovic, V. Marinkovic, and D. Agbaba, “First-order UV-derivative spectrophotometry in the analysis of omeprazole and pantoprazole sodium salt and corresponding impurities,” Journal of Pharmaceutical and Biomedical Analysis, vol. 32, no. 4-5, pp. 1019–1027, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. R. M. Orlando and P. S. Bonato, “Simple and efficient method for enantioselective determination of omeprazole in human plasma,” Journal of Chromatography B, vol. 795, no. 2, pp. 227–235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. Q. B. Cass, V. V. Lima, R. V. Oliveira, N. M. Cassiano, A. L. G. Degani, and J. Pedrazzoli, “Enantiomeric determination of the plasma levels of omeprazole by direct plasma injection using high-performance liquid chromatography with achiral-chiral column-switching,” Journal of Chromatography B, vol. 798, no. 2, pp. 275–281, 2003. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ekpe and T. Jacobsen, “Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography,” Drug Development and Industrial Pharmacy, vol. 25, no. 9, pp. 1057–1065, 1999. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  19. J. F. Marier, M. C. Dubuc, E. Drouin, F. Alvarez, M. P. Ducharme, and J. L. Brazier, “Pharmacokinetics of omeprazole in healthy adults and in children with gastroesophageal reflux disease,” Therapeutic Drug Monitoring, vol. 26, no. 1, pp. 3–8, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. A. M. Wahbi, O. Abdel-Razak, A. A. Gazy, H. Mahgoub, and M. S. Moneeb, “Spectrophotometric determination of omeprazole, lansoprazole and pantoprazole in pharmaceutical formulations,” Journal of Pharmaceutical and Biomedical Analysis, vol. 30, no. 4, pp. 1133–1142, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Rahman, Z. Bano, S. N. H. Azmi, and M. Kashif, “A kinetic spectrophotometric method for the determination of lansoprazole in pharmaceutical formulations,” Journal of the Serbian Chemical Society, vol. 71, no. 10, pp. 1107–1120, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Miura, H. Tada, and T. Suzuki, “Simultaneous determination of lansoprazole enantiomers and their metabolites in plasma by liquid chromatography with solid-phase extraction,” Journal of Chromatography B, vol. 804, no. 2, pp. 389–395, 2004. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  23. M. L. C. Montanari, Q. B. Cass, A. D. Andricopulo, A. Leitao, and C. A. Montanari, “Identification of chiral selectors for improved enantioseparation based on molecular interaction fields,” Analytica Chimica Acta, vol. 545, no. 1, pp. 33–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. N. Rahman and M. Kashif, “Initial-rate method for the determination of pantoprazole in pharmaceutical formulations using 1-fluoro 2,4-dinitrobenzene,” Pharmazie, vol. 60, no. 3, pp. 197–200, 2005. View at Google Scholar · View at Scopus
  25. Z. Y. Xie, D. F. Zhong, B. H. Yang, and X. Jin, Yaowu Fenxi Zazhi, vol. 24, pp. 1–4, 2004.
  26. Z. Xie, X. Chen, F. Jin, and D. Zhong, “Simultaneous determination of pantoprazole and Its two metabolites in dog plasma by HPLC,” Journal of Chromatographic Science, vol. 43, no. 5, pp. 271–275, 2005. View at Google Scholar · View at Scopus
  27. C. V. Garcia, C. S. Paim, and M. Steppe, “New liquid chromatographic method for determination of rabeprazole sodium in coated tablets,” Journal of Association of Official Analytical Chemists International, vol. 87, no. 4, pp. 842–846, 2004. View at Google Scholar
  28. Y. Yokoyama, N. Kishi, H. Ohe, M. Tanaka, and N. Asakawa, “Fundamental processes for LC- NMR and its applications,” Analytical Sciences, vol. 19, no. 4, pp. 262–263, 1998. View at Google Scholar · View at Scopus
  29. D. V. Bharathi, K. K. Hotha, B. Jagadeesh et al., “Simultaneous estimation of four proton pump inhibitors - Lansoprazole, omeprazole, pantoprazole and rabeprazole: development of a novel generic HPLC-UV method and its application to clinical pharmacokinetic study,” Biomedical Chromatography, vol. 23, no. 7, pp. 732–739, 2009. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus
  30. M. Noubarani, “Improved HPLC method for determination of four PPis, omeprazole, pantoprazole, lansoprazole and rabeprazole in human plasma,” Journal of Pharmacy and Pharmaceutical Sciences, vol. 13, no. 1, pp. 1–10, 2010. View at Google Scholar · View at Scopus
  31. “Validationof analytical procedures: text and methodology,” http://www.ich.org/cache/compo/363-272-1.html#Q2A.